Business Model

Healthcare Economics (HCE) provides consulting services for contract manufacturing, tech transfers, joint ventures, business development, and portfolio management for small and large molecule development and commercialization. These products and services are placed with small, medium and large manufacturers keen to enter and expand within the biotech and pharmaceutical markets. HCE will link FDA and EMA approved manufacturers of both bulk and finished pharmaceuticals with business partners in search of these products to commercialize and capture market share.

It has been universally understood and agreed that developing counties will fuel future growth opportunities and market expansion. Many first world manufacturers are keen to enter new and developing markets with their product offerings and many second and third world FDA and EMA approved manufacturers are eager to enter the first world markets but find it difficult to exploit these opportunities.

HCE will leverage its extensive network to assist firms to meet their objectives. Additionally, our talented consultants will also provide commercial development, contracting services, market access and reimbursement support to biotech and pharmaceutical firms and further downstream to wholesalers, retailers and government entities requesting such services. This virtual business model ensures successful application, cooperation, and proven results.